Beyond vision: The emotional toll of advanced diabetic retinopathy response to the letter

We thank Gui et al. for their thoughtful correspondence regarding our recent paper, ‘Beyond vision: The emotional toll of advanced diabetic retinopathy’.1 We appreciate their engagement with our work and their emphasis on the importance of inclusive psychosocial research among people living with advanced diabetic retinopathy (DR). We agree that diabetes-related cognitive impairment is common among individuals with long-standing diabetes and that emotional distress may persist even in the presence of cognitive decline. Their commentary highlights an important and under-recognised methodological challenge in psychosocial research involving clinically complex populations. We were mindful that people attending specialist diabetic retinopathy clinics often experience heightened anxiety related to diagnosis, disease progression and treatment decisions. In this context, we sought to minimise participant burden and avoid introducing additional distress by administering more complex or cognitively demanding assessments during routine clinical encounters. Notwithstanding this, we wish to clarify that although our study protocol specified exclusion criteria relating to cognitive impairment that could potentially preclude engagement with study procedures, no individuals were excluded from the study on this basis. All individuals who attended the specialist DR clinics during the recruitment period and who consented to participate completed the DDS-17 questionnaire and were included in the analysis. Consequently, it is unlikely that this approach introduced selection bias related to cognitive status. The use of validated self-report instruments, including the DDS-17, was guided by their established validation parameters, which require a degree of comprehension and self-reflection to ensure meaningful and interpretable responses. This approach is consistent with the existing literature and reflects common practice in psychosocial research. We welcome the authors' proposal of a stratified, multimodal assessment framework incorporating cognitive screening, adapted tools and proxy or clinician-rated measures. Such an approach is methodologically robust and ethically sound and represents an important direction for future research. Future studies would benefit from prospectively incorporating these inclusive strategies, alongside clearly defined analytical plans to account for data derived from multiple sources. This would strengthen the evidence base and support the development of psychosocial interventions that are responsive to the needs of cognitively vulnerable individuals with advanced DR.

Authors

Institutions

Publication Details

Journal
Diabetic Medicine
Published
2026-03-20
DOI
https://doi.org/10.1111/dme.70296
Primary Topic
Diabetes Management and Education
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Beyond vision: The emotional toll of advanced diabetic retinopathy response to the letter

Hellena Hailu Habte‐Asres, Sarah A. Afuwape, Clara Nartey
Diabetic Medicine
Diabetes Management and Education
article

Beyond vision: The emotional toll of advanced diabetic retinopathy response to the letter

Hellena Hailu Habte‐Asres, Sarah A. Afuwape, Clara Nartey
article en

Abstract

We thank Gui et al. for their thoughtful correspondence regarding our recent paper, ‘Beyond vision: The emotional toll of advanced diabetic retinopathy’.1 We appreciate their engagement with our work and their emphasis on the importance of inclusive psychosocial research among people living with advanced diabetic retinopathy (DR). We agree that diabetes-related cognitive impairment is common among individuals with long-standing diabetes and that emotional distress may persist even in the presence of cognitive decline. Their commentary highlights an important and under-recognised methodological challenge in psychosocial research involving clinically complex populations. We were mindful that people attending specialist diabetic retinopathy clinics often experience heightened anxiety related to diagnosis, disease progression and treatment decisions. In this context, we sought to minimise participant burden and avoid introducing additional distress by administering more complex or cognitively demanding assessments during routine clinical encounters. Notwithstanding this, we wish to clarify that although our study protocol specified exclusion criteria relating to cognitive impairment that could potentially preclude engagement with study procedures, no individuals were excluded from the study on this basis. All individuals who attended the specialist DR clinics during the recruitment period and who consented to participate completed the DDS-17 questionnaire and were included in the analysis. Consequently, it is unlikely that this approach introduced selection bias related to cognitive status. The use of validated self-report instruments, including the DDS-17, was guided by their established validation parameters, which require a degree of comprehension and self-reflection to ensure meaningful and interpretable responses. This approach is consistent with the existing literature and reflects common practice in psychosocial research. We welcome the authors' proposal of a stratified, multimodal assessment framework incorporating cognitive screening, adapted tools and proxy or clinician-rated measures. Such an approach is methodologically robust and ethically sound and represents an important direction for future research. Future studies would benefit from prospectively incorporating these inclusive strategies, alongside clearly defined analytical plans to account for data derived from multiple sources. This would strengthen the evidence base and support the development of psychosocial interventions that are responsive to the needs of cognitively vulnerable individuals with advanced DR.

Diabetic Medicine
Moorfields Eye Hospital NHS Foundation Trust (GB), Royal Free London NHS Foundation Trust (GB), King's College London (GB), Moorfields Eye Hospital (GB), University College London (GB)
Reduced inequalities
Openalex Percentile: Top 16%
Diabetes Management and Education
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.